Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With Preeclampsia.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 12 Mar 2012
At a glance
- Drugs Celecoxib (Primary)
- Indications Preeclampsia
- Focus Therapeutic Use
- 12 Mar 2012 Actual end date changed from Dec 2010 to Jan 2010 as reported by linicalTrials.gov.
- 19 Jan 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 19 Jan 2010 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.